GNLX:NASDAQ
Genelux Corp
2,52 US$
arrow_downward
-1,13%(-0,029) 1K
13-okt, 10:07:17 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoGNLX tikeri uchun statistika yaratilmoqda...
Ochish
2,53 US$
Yuqori
2,54 US$
Past
2,49 US$
Bozor kapitali
113,85 mln
Oʻrtacha hajm
249,28 ming
Hajmi
15,80 ming
52 haftalik eng yuqori
8,54 US$
52 haftalik eng past
2,29 US$
Aksiya boʻyicha daromad
-0,87 US$
Beta
0,59
Muomaladagi aksiyalar
45,24 mln
Xodimlar soni
26
Ochish
2,53 US$
Yuqori
2,54 US$
Past
2,49 US$
Bozor kapitali
113,85 mln
Oʻrtacha hajm
249,28 ming
Hajmi
15,80 ming
52 haftalik eng yuqori
8,54 US$
52 haftalik eng past
2,29 US$
Aksiya boʻyicha daromad
-0,87 US$
Beta
0,59
Muomaladagi aksiyalar
45,24 mln
Xodimlar soni
26
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
https://www.dars.gov.et/
·
1 oy oldin
GNLX Q2 2026 Earnings: Wider-than-Expected Loss Reflects Continued Clinical Investment - Consensus Miss Rate
Profil
Genelux Corporation is a publicly traded late clinical-stage company developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company’s most advanced product candidate, Olvi-Vec, is a proprietary, modified strain of the vaccinia virus, a stable DNA virus with a large engineering capacity.
The core of Genelux’s discovery and development efforts revolves around the company's proprietary CHOICE™ platform from which the Company has developed an extensive library of isolated and engineered oncolytic vaccinia virus immunotherapeutic product candidates, including Olvi-Vec.
The company is currently entered its pivot Phase 3 study in Platinum resistant/refractory ovarian cancer. Trial design based on VIRO-15 Phase 2 trial which showed independent anti-tumor activity of Olvi-Vec and reversal of platinum resistance in the TME. Wikipedia
Genelux Corp haqida
CEO-
Xodimlar soni26
Asos solingan2001
Bosh ofislarWestlake Village, Kaliforniya, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytgenelux.com